Induction and Maintenance Therapy for Fit Patients With AML Without Targetable Mutations
CCO Oncology Podcast01/10/22 • 14 min
In this podcast episode, Ashley Leak Bryant, PhD, RN, OCN, FAAN, discusses therapeutic options for younger, fit patients with AML and no targetable mutations. Topics include:
- Induction chemotherapy and consolidation therapy
- Use of gemtuzumab ozogamicin
- Management of sinusoidal obstruction syndrome
- Nursing considerations for younger, fit patients with AML
Presenter:
Ashley Leak Bryant, PhD, RN, OCN, FAAN
Associate Professor
School of Nursing
UNC Lineberger Comprehensive Cancer Center
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
01/10/22 • 14 min
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/cco-oncology-podcast-195050/induction-and-maintenance-therapy-for-fit-patients-with-aml-without-ta-18922024"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to induction and maintenance therapy for fit patients with aml without targetable mutations on goodpods" style="width: 225px" /> </a>
Copy